openPR Logo
Press release

awareness campaigns for weight management is expected to be a major driver for Orlistat market growth

12-23-2019 06:54 AM CET | Health & Medicine

Press release from: Coherent Market Insights

Orlistat Market

Orlistat Market

Roche Holding AG, a pharmaceutical company, launched its new campaign ‘New You Weight Consciousness Advocacy Campaign’, with an aim to increase awareness among the populace regarding obesity and its treatment options. Such awareness campaigns is expected increase the adoption of weight management medication treatments, which in turn, is expected to boost growth of the Orlistat market size.

Re-launch of Orlistat products is expected to drive the market growth. For instance, in February 2018, H2 Pharma, LLC. partnered with Cheplapharma Arzneimittel GmbH and re-launched Xenical Capsules, which was acquired from F.Hoffman-La Roche. Xenical capsules were re-launched to increase awareness regarding medication related to weight management, this in turn, is expected to boost orlistat market growth.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1878

Robust pipeline is expected to boost the market growth over the forecast period. For instance, orlistat by University of Texas South Western Medical center is in phase 2 since 2015. Orlistat is used for the treatment of hyperlipoproteinemia type 1. Hyperlipoproteinemia type 1 is caused due to deficiency of lipoprotein lipase. SLx-4090 by University of Texas South Western Medical center is in phase 2 to study its effectiveness in combination with Orlistat. SLx-4090 is used to treat high blood fat level mostly observed in hyperlipoproteinemia type 1 patients.

Rising prevalence of obesity is expected to fuel orlistat market growth. According to a survey conducted by National Family Health Survey in 2015, in India, over 9.8 million men and over 20 million women were recorded to be obese. India stands second-highest in the world for obese children, with the number constantly increasing by 3-5 million patients every year.

Availability of alternate methods such as devices that reduce fat, in turn, pose as a major factor restraining growth of the Orilstat market. For instance, Ultra shape fat melting device helps remove body fat using pulsed ultrasound waves that neither use heat nor cold to remove body fat.

Orlistat Market Regional Analysis:-

North America is expected to hold a dominant position in the global orlistat market, owing to high prevalence of obesity in the region. According to a study conducted by National Institute of Health in 2016, over 38% of adults aged 20 years and above are obese, over 17.2% of children aged 7 years and above are obese, and over 30% of the population is considered to be overweight in the U.S. According to a study conducted by World Health Organization, in 2015, over 40 million children aged 5 years and above were overweight in the U.S. Thus, high prevalence of obesity is expected to fuel North America Orlistat market growth over the forecast period.

Europe Orlistat market is expected to show significant growth due to expected launch of new generic version of Orlistat over the forecast period. For instance, in 2011, Teva Pharmaceutical Industries Ltd., launched generic version of Xenical Capsules in the U.K., which was manufactured by Roche Holding AG. Xenical Capsules is used for the treatment of obesity as well as for those whose BMI is greater than or equal to 30kg/m2 and overweight patients. This in turn, is expected to boost Orlistat market growth, as the drug seems more affordable thus, being accessible to a large pool of patients.

Orlistat Market Key Players:-

Key players operating in the Orlistat market include Roche Holding AG, GlaxoSmithKline, Teva Pharmaceutical Industries Ltd, Sandoz Pharmaceuticals, STADA–VN J.V. Co., Ltd., Hexal AG., National Company for Pharmaceutical Industry, Lunan Pharmaceutical group Corporation Ltd., ZEIN Pharmaceutical Co. Ltd., HISUN Pharmaceuticals Co. Ltd., Taj Pharmaceuticals Ltd., D.M. Pharma, China Zhongshan Pharma Co. Ltd., and Kabir Life Sciences and Research Pvt. Ltd.

Request Sample Pages @ https://www.coherentmarketinsights.com/insight/request-sample/1878

Orlistat Market Taxonomy:-

The global Orlistat market is segmented based on distribution channel and region:

By Distribution channel:-

Hospitals/Clinics
Online Pharmacies
Retail Pharmacies
By Region:-

North America
Europe
Latin America
Asia Pacific
Middle East
Africa

Contact:

Name: Mr. Raj Shah

Phone: US +12067016702 / UK +4402081334027

Email: sales@coherentmarketinsights.com

About CoherentMarketInsights

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release awareness campaigns for weight management is expected to be a major driver for Orlistat market growth here

News-ID: 1883043 • Views: 526

More Releases from Coherent Market Insights

Software Defined Networking Market Trend Analysis, Latest Revenue Figures, Business Outlines, Growth Insights, and Forecasts until 2030 | Alcatel-Lucent, Huawei Technologies, Cisco Systems, Inc., Juniper Networks
Software Defined Networking Market Trend Analysis, Latest Revenue Figures, Busin …
Coherent Market Insights' current report, Global "Global Software Defined Networking Market Size, Share, Regions, Type, Application, Pricing, Trends, Growth, Segments, Opportunities and Forecast 2023-2030", is a valuable source of insightful data for developing business strategies. It intends to draw attention to major trends, growth possibilities, and the competitive environment. Businesses must grasp the characteristics of their various industries in order to make well-informed decisions and plan their strategies effectively in
Construction Drone Market Analysis by Size, Precise Development Outlook, and Revenue Status From 2023-2030 | 3D Robotics, Inc., AeroVironment, Inc., DJI
Construction Drone Market Analysis by Size, Precise Development Outlook, and Rev …
Coherent Market Insights' current report, Global "Global Construction Drone Market Size, Share, Regions, Type, Application, Pricing, Trends, Growth, Segments, Opportunities and Forecast 2023-2030", is a valuable source of insightful data for developing business strategies. It intends to draw attention to major trends, growth possibilities, and the competitive environment. Businesses must grasp the characteristics of their various industries in order to make well-informed decisions and plan their strategies effectively in today's
Contract Packaging Market Segment Analysis, Regional Demands, Trends, End Users and Forecast Period of 2030 | Aaron Thomas Company, Multipack Solutions
Contract Packaging Market Segment Analysis, Regional Demands, Trends, End Users …
The latest research study released by Coherent Market Insights on "Contract Packaging Market" with 100+ pages of analysis on business strategy taken up by emerging industry players, geographical scope, market segments, product landscape and price, and cost structure. It also assists in market segmentation according to the industry's latest and upcoming trends to the bottom-most level, topographical markets, and key advancement from both market and technology-aligned perspectives. Each section of
Copper Plate Paper Market Trends, Growth and Key Players, Future Demand, Size and Forecast Estimation by 2030 | International Paper Company, Domtar Corporation
Copper Plate Paper Market Trends, Growth and Key Players, Future Demand, Size an …
The latest research study released by Coherent Market Insights on "Copper Plate Paper Market" with 100+ pages of analysis on business strategy taken up by emerging industry players, geographical scope, market segments, product landscape and price, and cost structure. It also assists in market segmentation according to the industry's latest and upcoming trends to the bottom-most level, topographical markets, and key advancement from both market and technology-aligned perspectives. Each section

All 5 Releases


More Releases for Orlistat

The Basic Information About Orlistat
According to statistics from the World Health Organization (WHO), nearly 2 billion people are overweight or obese worldwide. Every year, overweight or obesity causes 2.8 million deaths. What 's Orlistat ? Orlistat is a lipase inhibitor used in the treatment of obesity that works by inhibiting fat-metabolizing enzymes. It was originally approved by the FDA in 1999 as the prescription drug Exenical, was approved in 2007 as the over-the-counter
Global Orlistat Market 2021 Industry Dynamics, Segmentation and Competition Anal …
MarketsandResearch.biz has introduced a new report titled Global Orlistat Market Growth 2021-2026 into its database that’s shaped by the means of primary and secondary research processes. The report comprises a detailed study of the along with the industry trends, size, share, growth drivers, challenges, competitive analysis, and revenue. The report includes an analysis of the overall global Orlistat market competition as well as the product portfolio of major players functioning in the market.
Orlistat Market Market - Size, Share, Outlook, and Forecast till 2026
Orlistat is a drug that is used to treat obesity by preventing the absorption of fats from human diet. It acts as a lipase inhibitor to carry out this process and therefore, the caloric intake is reduced. This drug is usually used along with a healthcare provider-supervised reduced-calorie diet. Orlistat, a saturated derivative of lipstatin, was chosen for the development of an anti-obesity drug due to its simplicity and stability.
Orlistat Market: Overview with Detailed Analysis, Competitive landscape Forecast …
Orlistat Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Orlistat market research report is a professional and in-depth study on the current state of Orlistat Industry. The Orlistat Market research report covers the present scenario and the growth prospects of the global Orlistat industry
Orlistat Market 2017: Keyplayers Roche, GSK group, Teva, Sandoz(Novartis)
QY Research Groups has published its new and latest market report based on thorough research on the Orlistat Market . This detailed, all-inclusive report renders an integrated approach to growth of the market along with an elaborate and accurate analysis of the complete competitive situation of this market on a global level with the key market trends and newest technologies, being a major part in the market’s growth during the
Orlistat Market to Witness A Pronounce Growth during 2022 Forecast in Top Countr …
The “Global Orlistat Market Research Report” is a professional and in-depth study on the current state of the Orlistat Market. The study offers an insight into current and future market trends, key drivers and restraints, market strategies of key market players along with detailed segmentation and forecast. The study offers industry overview by covering basic aspects such as product definition and classification, market size and share of segments and sub-segments.